Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

19 April 2013: Clinical Research  

Cognitive functions in patients with liver cirrhosis: A tendency to commit more memory errors

Irena Ciećko-Michalska ABDEFG , Jan Wójcik BE , Magdalena Senderecka BE , Mirosław Wyczesany CD , Marek Binder BD , Jakub Szewczyk B , Tomasz Dziedzic B , Agnieszka Słowik B , Tomasz Mach D

DOI: 10.12659/MSM.883890

Med Sci Monit 2013; 19:283-288

0 Comments

Abstract

BACKGROUND: Minimal hepatic encephalopathy (MHE) is the mildest form of hepatic encephalopathy (HE). For diagnostic purposes, 2 alternative batteries of psychometric screening tests are recommended. They differ from each other in terms of the cognitive domains assessed. The research was designed to provide a profile of cognitive functioning in patients with liver cirrhosis, using an assessment that covers a wider range of cognitive functions than the usual screening battery.

MATERIAL AND METHODS: We examined 138 persons, including 88 with liver cirrhosis and 50 healthy volunteers. The Mini Mental State Examination (MMSE) was used for screening and excluding advanced cognitive impairment. Then, to assess cognitive functions in more detail, the following tests were used: Auditory Verbal Learning Test (AVLT), Letter and Semantic Fluency Tests (LF and SF), Trail Making Test (TMT A&B), Digit Symbol Test (DST), Block Design Test (BDT), and Mental Rotation Test (MRT). The MRT task has not been used in MHE diagnosis so far. Finally, 57 patients and 48 controls took part in the entire study.

RESULTS: Patients with liver cirrhosis commit significantly more errors of intrusions in the AVLT during the delayed free recall trial. Results significantly deviating from the norm in at least 2 tests were found only in 7 cirrhosis patients.

CONCLUSIONS: The results do not provide any specific profile of cognitive disturbances in MHE, but suggest that cirrhosis patients have a tendency to commit more memory errors, probably due to subtle impairments of executive function.

Keywords: Neuropsychological Tests, Memory Disorders - physiopathology, Memory, Liver Cirrhosis - physiopathology, Demography, Cognition - physiology, Psychometrics

Background

Minimal hepatic encephalopathy (MHE) is the mildest form of overt hepatic encephalopathy (HE). Its occurrence is estimated at 30–84% according to different authors and it strongly depends on the diagnostic methods used, as well as the considered population [1–4]. The occurrence of MHE in the Polish population was estimated by Habior et al to be 17.6–31.3% [5]. MHE is a subtle cognitive impairment that can be detected with a neuropsychological assessment [67]. Other techniques using neurophysiological or neuroimaging methods can reveal differences in group comparisons; however, individual diagnosis on their basis is currently not possible [8–12]. MHE affects quality of life, as well as specific abilities like driving (it increases the risk of road accidents) [13,14], and can also lead to the development of overt hepatic encephalopathy, which is linked with increased mortality [3,4,15,16]. A study by Hilsabeck et al showed that cognitive disorders can be observed in patients with viral hepatitis C, even when no cirrhosis symptoms are observed. Intensification of cognitive deficits is related to advancement of the liver fibrosis process [17]. From the clinical point of view, it is essential to diagnose MHE as soon as possible in individual cases. This provides an opportunity for immediate commencement of treatment, which, according to numerous studies, significantly improves the prognosis [1,4,18,19].

However, the diagnosis of MHE is difficult, as there are no clear clinical symptoms that can be easily observed during a medical examination. Hence, there are attempts to employ a cognitive assessment in a more detailed way than provided by the Mini Mental State Examination (MMSE) scale. On the other hand, a sufficiently easy method would be preferred in order to avoid having to perform a time consuming and less available neuropsychological examination [6,7].

Currently, use of a Psychometric Hepatic Encephalopathy Score (PHES) is recommended. This consists of 4 paper-pencil tests: Digit Symbol Test (DST), Line Drawing Test (LDT), Serial Dotting Test (SDT), and Trail Making Test (TMT; comprised of parts A and B, but in the MHE literature sometimes referred to as 2 separate number connection tests, which is incorrect) [6,7]. All these tests are performed under time pressure. They require copying of simple graphic symbols or drawing lines from one place to another, or within a defined drawing path. Apart from the TMT, which is a commonly used neuropsychological test, the rest are not widely used in neuropsychological assessment. It is not clear which detailed aspects of cognitive functioning they measure besides psychomotor speed, which depends on attentional, motor, and perceptual efficiency. Moreover, all the information from the individual performance scores is obscured when the single total PHES score is calculated. The sensitivity of PHES is also mediated by age and education level [20].

On the other hand, the Commission on Neuropsychological Assessment of Hepatic Encephalopathy of the International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) recommends using a battery other than PHES, the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) [21]. It is a simplified routine of neuropsychological assessment, which allows for separate examination of the following cognitive domains: immediate memory, visuo-spatial and construction abilities, attention, language, and delayed memory. Among other things, RBANS tasks require figure copying, learning a list of words and later recall of figure and words, picture naming, and choice of correct line orientation that matches the target line. Contrary to the PHES, which is used only in MHE research, the RBANS can also be used in screening for either dementia or cognitive impairments in other diseases [22,23].

These 2 methods differ in terms of the range of the examined cognitive functions. The PHES score depends to a greater extent on psychomotor speed. The RBANS score, on the other hand, depends on efficiency in other domains. However, although RBANS assesses a wider range of abilities, it does not allow for measuring executive functions, but the PHES includes the TMT test, which does measure them. Hence, the 2 methods can detect a decrease in cognitive functioning in different groups of patients, which in consequence leads to inconsistent MHE diagnosis.

In the present study, a different way of assessing cognitive functions in patients with liver cirrhosis was used. It was expected that this would enable quantification of the abilities that are also covered by either PHES or RBANS. In addition to typical scores defined on the basis of performance time or number of correct responses, the number of errors was also considered. In typical neuropsychological assessment, when cognitive impairments are suspected it is of key importance to examine the number and type of errors committed, instead of global performance. However, this information is rarely taken into account during the examination of patients with liver cirrhosis. The aim of the study was to determine a profile of cognitive functioning in patients with liver cirrhosis and to determine the usability of typical clinical tests in the diagnosis of MHE.

Material and Methods

STATISTICAL ANALYSIS:

Due to violated normality assumption in the data distributions, results were analyzed using the non-parametric Mann-Whitney U test (neuropsychological data) and Kruskal-Wallis test (liver cirrhosis etiology). To avoid type-I errors (false positive) related to multiple comparisons, p-levels obtained in single analysis were corrected using the FDR (false discovery rate) procedure. The co-variation between the biochemical and neuropsychological data was analyzed with Spearman’s rho correlation.

Results

Demographic data in both groups are shown in Table 1. The MMSE scores did not reveal significant differences between the patient and the control group (29.03; SD 1.38 vs. 29.80; SD 0.50). Therefore, the cognitive abilities measured by this test were equal in both groups.

Significant differences between the groups were found in complete blood count for AST, ALT, AP, GGTP, ammonia (p<0.01), INR, and bilirubin level (p<0.05). In the clinical group, a decreased number of thrombocytes and a decreased level of albumin were observed, but did not reach statistical significance. The results of the biochemical tests are shown in Table 2. Neither biochemical nor neuropsychological differences were observed in relation to the various etiologies of liver cirrhosis in the clinical group. No correlations were found between biochemical and neuropsychological scores in any of the groups.

Neuropsychological test scores are shown in Table 3. As can be seen, more intrusions were found in the clinical group (0.59; SD 0.81) than in the control group (0.23; SD 0.59) in the AVLT delayed free recall trial (p<0.01).

The criterion of deviating more than 2 SD on at least 2 tests was fulfilled in 7 (12.3%) liver cirrhosis patients. However, more patients revealed such deviation on 1 of the tests only. This does not satisfy the MHE criteria, although it shows some selective cognitive impairments. The data are presented in Table 4.

Discussion

The only statistical difference between the clinical and the control group was found in the intrusions level in the AVLT delayed free recall. Intrusions can be interpreted as difficulty in distinguishing whether information currently present in the mind is a kind of recollection related to the task or an association not related to the task itself, which is called source monitoring [26]. In the cognitive model of intrusions it is assumed that they can result from natural processes organizing encoding and retrieval [29]. According to this model, all information that is temporarily stored in the short-term memory (STM) activates semantically or phonetically related information in the long-term memory (LTM). During the encoding phase, relevant task-related information can activate content from the LTM, which is not directly related to the task, and both can be encoded together. Retrieval in this model is described as activation of information in the LTM related to the retrieval cue. One recalled piece of information helps in the recall of another (e.g., one word from the list helps in the recall of the next word). Even when the information has been encoded properly, the retrieved information can activate content in LTM that is non-related to the task. Clinical data show that basic functions such as organizing and controlling information processing in memory can be assigned to the executive functions cognitive domain.

A high amount of intrusions in tests based on learning a list of words (such as AVLT) can be observed in frontal lesions [26] and in dementia, including Alzheimer’s disease (AD) [30]. AD impairs episodic memory at its early stages; this is the main reason for decreased AVLT performance. However, the relationship between intrusions in free recall trials and efficiency of the frontal lobes in AD has been proved [31]. An increase of intrusions was also found, to a lesser extent, in a group of schizophrenia patients with executive function disorders compared to those with schizophrenia but without executive impairments [32]. Similarly, the same effect was found in children with either Tourette syndrome or ADHD compared to a control group, even when executive functions tests did not show any changes [33]. Similar results were obtained in our study, where the measures of executive functions (TMT B, fluency tests) did not show an apparent decrease in performance. This suggests that the number of intrusions in AVLT is a very sensitive indicator in both mild and severe cognitive disorders and is related to other kinds of executive functions than those examined with the TMT B or fluency tests.

No significant differences were found in AVLT measures of short-term memory span (the first trial), learning process (sum of tests 1–5), or general index of encoding and retrieval (correct answers in delayed free recall trial), which suggests that the 2 groups do not differ in episodic memory, although some near-significant subtle differences were observed. Ortiz et al. [34] described episodic memory impairment measured with AVLT in MHE patients with subsequent improvement after liver transplantation. However, the number of errors was not considered in this study. It can be assumed that a larger sample would make our near-significant AVLT effects stronger, which is in line with the suggestion of specific memory impairments in MHE.

The tests in which the cirrhosis patients scored 2 SD below the mean were most often related to executive functions (TMT B and LF), to psychomotor speed (TMT A and DST), and to memory (AVLT). Executive dysfunction and bradyphrenia are symptoms of a subcortical profile of cognitive impairment, which is sometimes described in MHE patients [35]. However, there were only a few patients diagnosed with MHE according to the criteria used in our study. This does not allow us to reach conclusions about the specific profile of cognitive impairments. Recommendations for MHE diagnosis suggesting the use of neuropsychological tests (e.g., BDT, DST, or TMT) or screening batteries (e.g., PHES or RBANS) are designed for quantitative assessment. In such a case, the number of failed tests is taken into account, but not their specific kind. This is not theoretically satisfying, but in light of the obtained results, no further directions for clinical practice can be provided unless future research reveals more reliable data on the cognitive profile of MHE.

Conclusions

Among the many neuropsychological tests used in this study, only one showed significant differences in performance. It was found that patients with liver cirrhosis have a tendency to commit significantly more errors of intrusions in the AVLT test during the delayed free recall trial, but they perform relatively well in other kinds of tasks. Although no MHE-specific profile of cognitive deficits could be identified, our findings suggest that cirrhosis patients have a tendency to commit more memory errors. This was interpreted as a possible effect of subtle impairments of executive function.

References

1. Das A, Dhiman RK, Saraswat VA, Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis: J Gastroenterol Hepatol, 2001; 16; 531-35, pmid: 11350549

2. Gitlin N, Lewis DC, Hinkley L, The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy ambulant, non- shunted patient with cirrhosis: J Hepatol, 1986; 3; 75-82, pmid: 3745889

3. Groeneweg M, Quero JC, De Bruijn I, Subclinical hepatic encephalopathy impairs daily functioning: Hepatology, 1998; 28; 45-49, pmid: 9657095

4. Montgomery JY, Bajaj JS, Advances in the evaluation and management of minimal hepatic encephalopathy: Curr Gastroenterol Rep, 2011; 13; 26-33, pmid: 20924726

5. Habior A, Kraszewska E, Goś-Zając A, Minimalna encefalopatia u chorych z marskością wątroby – ocena metod diagnostycznych i częstości występowania: Postępy Nauk Medycznych, 2008; 11; 769-78 [in Polish]

6. Ferenci P, Lockwood A, Mullen K: Hepatology, 2002; 35; 716-21, pmid: 11870389

7. Dhiman RK, Saraswat VA, Sharma BK, Minimal hepatic encephalopathy: consensus statement of a working party of the Indian National Association for Study of the Liver. Indian National Association for Study of the Liver: J Gastroenterol Hepatol, 2010; 25; 1029-41, pmid: 20594216

8. Ciećko-Michalska I, Senderecka M, Szewczyk J, Event-related cerebral potentials for the diagnosis of subclinical hepatic encephalopathy in patients with liver cirrhosis: Adv Med Sci, 2006; 51; 273-77, pmid: 17357325

9. Ciećko-Michalska I, Wójcik J, Wyczesany M, Cognitive evoked response potentials in patients with liver cirrhosis without diagnosis of minimal or overt hepatic encephalopathy. A pilot study: J Physiol Pharmacol, 2012; 63; 271-76, pmid: 22791641

10. Ciećko-Michalska I, Binder M, Wyczesany M, Electrophysiological correlates of attentional processes in patients with liver cirrhosis without minimal or clinically-overt hepatic encephalopathy: J Physiol Pharmacol, 2012; 63; 339-46, pmid: 23070082

11. Montoliu C, Gonzalez-Escamilla G, Atienza M, Focal cortical damage parallels cognitive impairment in minimal hepatic encephalopathy: Neuroimage, 2012; 61; 1165-75, pmid: 22465844

12. Liao LM, Zhou LX, Le HB, Spatial working memory dysfunction in minimal hepatic encephalopathy: an ethology and BOLD-fMRI study: Brain Res, 2012; 1445; 62-72, pmid: 22325099

13. Wein C, Koch H, Popp B, Minimal hepatic encephalopathy impairs fitness to drive: Hepatology, 2004; 39; 739-45, pmid: 14999692

14. Bajaj JS, Hafeezullah M, Hoffmann RG, Navigation skill impairment: Another dimension of the driving difficulties in minimal hepatic encephalopathy: Hepatology, 2008; 47; 596-604, pmid: 18000989

15. Dhiman RK, Chawla YK, Minimal hepatic encephalopathy: time to recognise and treat: Trop Gastroenterol, 2008; 29; 6-12, pmid: 18564660

16. Romero-Gomez M, Boza F, Garcia-Valdecasas MS, Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy: Am J Gastroenterol, 2001; 96; 2718-23, pmid: 11569701

17. Hilsabeck RC, Perry W, Hassanein TI, Neuropsychological impairment in patients with chronic hepatitis C: Hepatology, 2002; 35; 440-446, pmid: 11826421

18. Bismuth M, Funakoshi N, Cadranel JF, Hepatic encephalopathy: from pathophisiology to therapeutic management: Eur J Gastroenterol Hepatol, 2011; 23; 8-22, pmid: 21099434

19. Dihman RK, Chawla YK, Minimal hepatic encephalopathy: Indian J Gastroenterol, 2009; 28; 5-16, pmid: 19529896

20. Duarte-Rojo A, Estradas J, Hernández-Ramos R, Validation of the psychometric hepatic encephalopathy score (PHES) for identifying patients with minimal hepatic encephalopathy: Dig Dis Sci, 2011; 56; 3014-23, pmid: 21461913

21. Randolph C, Hilsabeck R, Katao A, Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines: Liver Int, 2009; 29; 629-35, pmid: 19302444

22. Strauss E, Sherman EMS, Spreen O: Compendium of neuropsychological tests, 2006, New York, Oxford University Press

23. Randolph C: RBANS Retrieved July 19, 2012. http://www.rbans.com/

24. Folstein MF, Folstein SF, McHugh PR, “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician”: J Psychiatr Res, 1975; 12; 189-98, pmid: 1202204

25. Brzeziński J, Gaul M, Hornowska E, Skala Inteligencji Wechslera dla Dorosłych. Wersja Zrewidowana – Renormalizacja: Polska adaptacja WAIS-R (PL), 2004, Warszawa, PTP, Podręcznik [in Polish]

26. Lezak MD, Howieson DB, Loring DW: Neuropsychological assessment, 2004; 281-97, New York, Oxford University Press

27. Choynowski M, Kostro B, Podręcznik do Testu piętnastu słów: Testy psychologiczne w poradnictwie wychowawczo-zawodowym, 1977; 102-69, PWN, Warszawa [in Polish]

28. Vandenberg SG, Kuse AR, Mental rotations, a group test of three-dimensional spatial visualization: Percept Mot Skills, 1978; 47; 599-604, pmid: 724398

29. Kimball DR, Smith TA, Kahana MJ, The fSAM model of false recall: Psychol Rev, 2007; 114; 954-93, pmid: 17907869

30. Rouleau I, Imbault H, Laframboise M, Pattern of intrusions in verbal recall: comparison of Alzheimer’s disease, Parkinson’s disease, and frontal lobe dementia: Brain Cogn, 2001; 46; 244-49, pmid: 11527341

31. Desgranges B, Baron JC, Giffard B, The neural basis of intrusions in free recall and cued recall: a PET study in Alzheimer’s disease: Neuroimage, 2002; 17; 1658-64, pmid: 12414304

32. Fridberg DJ, Brenner A, Lysaker PH, Verbal memory intrusions in schizophrenia: associations with self-reflectivity, symptomatology, and neurocognition: Psychiatry Res, 2010; 179; 6-11, pmid: 20638729

33. Mahone EM, Koth CW, Cutting L, Executive function in fluency and recall measures among children with Tourette syndrome or ADHD: J Int Neuropsychol Soc, 2001; 7; 102-11, pmid: 11253836

34. Ortiz M, Córdoba J, Jacas C, Neuropsychological abnormalities in cirrhosis include learning impairment: J Hepatol, 2006; 44; 104-10, pmid: 16169117

35. McMcrea M, Cordoba J, Vessey G, Neuropsychological characterization and detection of subclinical hepatic encephalopathy: Arch Neurol, 1996; 53; 758-63, pmid: 8759982

In Press

Clinical Research  

Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...

Med Sci Monit In Press; DOI: 10.12659/MSM.951027  

Clinical Research  

Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...

Med Sci Monit In Press; DOI: 10.12659/MSM.950516  

Review article  

Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A Review

Med Sci Monit In Press; DOI: 10.12659/MSM.951283  

Clinical Research  

Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 Adults

Med Sci Monit In Press; DOI: 10.12659/MSM.950938  

Most Viewed Current Articles

17 Jan 2024 : Review article   10,187,196

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

13 Nov 2021 : Clinical Research   3,708,487

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788

0:00

14 Dec 2022 : Clinical Research   2,341,643

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research   706,524

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750